Sanxin Medical Releases 2026 Interim Report with Net Profit of 132 Million Yuan

Earnings
โดย Jiemian·CN·Read original
Summary · why it matters

Sanxin Medical released its 2026 interim report on August 25, 2026. Total operating revenue was 837 million yuan, and net profit attributable to the parent company was 132 million yuan. Net cash inflow from operating activities was 155 million yuan, down 17.81% from the same period last year. The company's latest asset-liability ratio was 36.43%, gross margin was 36.35%, ROE was 8.85%, and diluted earnings per share was 0.25 yuan.

Impact on stocks 1

Others▲ · 1 stocks
© 2026 MarketDXNews